Latest Articles
An immunodeficient patient with adenomyosis of the uterus complicated | IJWH - Dove Medical Press
An immunodeficient patient with adenomyosis of the uterus complicated | IJWH Dove Medical Press
Published: March 4, 2026, 5:54 a.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider
Published: Feb. 18, 2026, 3:28 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider
Published: Feb. 18, 2026, 3:28 p.m.
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment - NewsGram
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment NewsGram
Published: Feb. 11, 2026, 3:33 a.m.
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication - thehindu.com
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication thehindu.com
Published: Feb. 10, 2026, 9:33 a.m.
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication - The Hindu
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication The Hindu
Published: Feb. 10, 2026, 9:33 a.m.
AstraZeneca gets Indian regulator's nod to market cancer drug Imfinzi - Business Standard
AstraZeneca gets Indian regulator's nod to market cancer drug Imfinzi Business Standard
Published: Feb. 10, 2026, 9:10 a.m.
AstraZeneca gets CDSCO nod to market cancer drug Imfinzi for additional indication - The Economic Times
AstraZeneca gets CDSCO nod to market cancer drug Imfinzi for additional indication The Economic Times
Published: Feb. 10, 2026, 8:44 a.m.
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug - CNBC TV18
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug CNBC TV18
Published: Feb. 10, 2026, 6:11 a.m.
AstraZeneca Pharma India Gets CDSCO Nod for Cancer Drug Imfinzi - Whalesbook
AstraZeneca Pharma India Gets CDSCO Nod for Cancer Drug Imfinzi Whalesbook
Published: Feb. 10, 2026, 5:34 a.m.
Link copied to clipboard!